Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 3, 1996, Pages 507-517

  Makino, Naoki ^a   Hata, Tomoji ^a   Sugano, Masahiro ^a   Dixon, Ian M C ^b   Yanaga, Takashi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Angiotensin converting enzyme; Angiotensin II receptor; Angiotensin type 1 receptor; Collagen; Myocardial infarction; Na+ Ca2+ exchange

Indexed keywords

4' [(2 CYCLOPROPYL 7 METHYL 3H IMIDAZO[4,5 B]PYRIDIN 3 YL)METHYL][1,1' BIPHENYL] 2 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART HEMODYNAMICS; HEART HYPERTROPHY; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART WEIGHT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM CALCIUM EXCHANGE; SYSTOLIC BLOOD PRESSURE;

ANIMALIA;

EID: 0029925141     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0047     Document Type: Article

References (43)

1. ANVERSA PD, SONNENBLICK EH, 1991. Ischemic cardiomyopathy: pathophysiologic mechanisms. Prog Cardiovasc Dis 33: 49-70.
2. BAKER KM, BOOZ GW, DOSTAL DE, 1992. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Ann Rev Physiol 54: 227-241.
3. BERGMAN I, LOXLEY R, 1961. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 35: 1961-1965.
4. BRILLA CG, PICK R, TAN LB, JANICKI JS, WEBER KT, 1990. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67: 1355-1364.
5. CAPASSO JM, LI P, MEGGS L, HERMAN MV, ANVERSA P, 1994. Efficacy of angiotensin-converting enzyme inhibition and ATI receptor blockade on cardiac pump performance after myocardial infarction in rats. J Cardiovasc Pharmacol 23: 584-593.
6. CUSHMAN DW, CHEUNG HS, 1971. Concentrations of angiotensin-converting enzyme in tissue of the rat. Biochim Biophys Acta 250: 261-265.
7. DIXON IMC, HATA T, DHALLA NS, 1992. Sarcolemmal calcium transport on congestive heart failure due to myocardial infarction in rats. Am J Physiol 262: H1387-H1394.
8. DOSTAL DE, ROTHBLUM KN, CHERNIN MI, COOPER GR, BAKER KM, 1992a. Intracardiac detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart. Am J Physiol 263: C838-C850.
9. DZAU VJ, 1989. Short-and long-term determinations of cardiovascular function and therapy: contributions of circulating and tissue renin-angiotensin systems. J Cardiovasc Pharmacol 14[Suppl. 4]: S1-S5.
10. FORT PH, MARTY I, PIECHACZYK M, SABROUTY SEI, DANI CH, JEANTEUR PH, BLANCHARD JM. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucl Acids Res 13: 1431-1442.
11. GOTTLIEB SS, DICKSTEIN K, FLECK E, KOSTIS J, LEVINE TB, LEJEMTEL T, DEKOCK M, 1993. Hemodynamic and neurohormonal effects of angiotensin II antagonist losartan in patients with congestive heart failure. Circulation 88: 1602-1609.
12. GROSSMAN WD, JONES D, MCLAURIN LP, 1975. Wall stress and patients with hypertrophy in the human left ventricle. J Clin Invest 56: 56-64.
13. HIRSCH AT, TALSNESS CE, SCHUNKERT H, PAUL M, DZAU VJ, 1991. Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 69: 475-482.
14. HIRSCH AT, TALSNESS CE, SMITH AD, SCHUNKERT H, INGELFINGER JR, DZAU VJ, 1992. Differential effects of captopril and enlapapril on tissue renin-angiotensin systems in experimental heart failure. Circulation 86: 1566-1574.
15. KOJIMA M, SHIOJIMA I, YAMAZAKI T, KOMURO I, YUNZENG Z, YING W, MIZUNI T, UEKI K, TOBE K, KADOWAKI T, NAGAI R, YAZAKI Y, 1994. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 89: 2204-2211.
16. LINDPAINTNER K, GANTEN D, 1991. The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. Circ Res 68: 905-921.
17. LINDPAINTNER K, LU W, NIEDERMAJER N, JUST H, GANTEN D, DREXLER H, 1993. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol 25: 133-143.
18. LOWRY OH, ROSENBROUGH NJ, FARR AL, RANDELL RJ, 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
19. MAKINO N, MATSUI H, MASUTOMO K, HATA T, YANAGA T. 1993. Effects of angiotensin converting enzyme inhibitor on regression in cardiac hypertrophy. Mol Cell Biochem 119: 23-28.
20. MEGGS LG, COUPET GJ, HUANG H, CHENG P, LI P, CAPASSO JM, HOMCY CJ, ANVERSA P. 1993. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ Res 72: 1149-1162.
21. MIMRAN A, TARGHETTA R, LAROCHE B, 1980. The antihypertensive effect of captopril, evidence of an influence of kinins. Hypertension 2: 732-737.
22. MORI N, ISHIHARA H, MATSUOKA T, SAITO I, 1994. Antihypertensive, antimyocardial hypertrophic and renal protective effects of E4177, on angiotensin II AT1 receptor antagonist, in rat (Abstract). Can J Physiol Pharmacol 72 [Suppl. 1]: 131.
23. MUKHERJEE D, SEN S, 1991. Alteration of collagen phenotypes in ischemic cardiomyopathy. 88: 1141-1146.
24. MURPHY TJ, ALEXANDER RW, GRIENDLING KK, RUNGE MS, BERSTEIN KE, 1991. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature (London) 351: 233-235.
25. OKUNISHI H, SONG K, OKA Y, KOBAYASHI T, KAWAMOTO T, ISHIHARA H, MORI N, MIYAZAKI M, 1993. In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E-4177. Jpn J Pharmacol 62: 239-244.
26. OLIVETTI G, CAPASSO JM, MEGGS LG, SONNENBLICK EH, ANVERSA P, 1991. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 68: 856-869.
27. PFEFFER MA, PFEFFER JM, STEINBERG C, FINN P, 1985. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72: 406-412.
28. PFEFFER MA, BRAUNWALD E, 1990. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 81: 1161-1172.
29. PFEFFER JM, 1991. Progressive ventricular dilation in experimental myocardial infarction and its attenuation by angiotensin-converting enzyme inhibition. Am J Cardial 68: 17D-25D.
30. PFEFFER MA, BRAUNWALD E, MOYE LA, BASTA L, BROWN J, CUDDY TE, DAVIS BR, GELTMAN EM, GOLDMAN S, FLAKER GC, 1992. Effect of captopril on myocardial mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial: the SAVE investigation. N Engl J Med 327: 669-677.
31. PITTS BJR, 1979. Stoichiometry of sodium-calcium exchange in cardiac sarcolemmal vesicles. J Biol Chem 254: 6232-6235.
32. RAYA TE, FONKEN SJ, LEE RW, 1991. Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model for heart failure. Am J Hypertens 4: 334S-340S.
33. ROGG H, SCHMID A, DE GASPANO M, 1990. Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium. Biochem Biophys Res Commun 173: 416-422.
34. RUZICKA M, YUAN B, LEENEN FHH, 1994. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. Circulation 90:484-491.
35. SADOSHIMA J, XU Y, SLAYTER HS, IZUMO S, 1993a. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vivo. Cell 75: 977-984.
36. SADOSHIMA J, IZUMO S, 1993b. Molecular characterization of angiotensin II induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblast: Critical role of the AT1 receptor subtype. Circ Res 73: 413-423.
37. 2+-dependent signaling. Circ Res 76: 1-15.
38. SCHUNKERT H, DZAU VJ, TANG SS, HIRSCH AT, APSTREIN CS, LORELL H, 1990. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effect on coronary resistance, contractility, and relaxation. J Clin Invest 86: 1913-1921.
39. SCHUNKERT H, SADOSHIMA J, CORNELIUS T, KAGAYA Y, WEINBERG ET, IZUMO R, REIGGER G, LORELL BH, 1995. Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res 76: 480-497.
40. SUZUKI J, MATSUBARA H, URAKAMI M, INADA M, 1993. Rat angiotensin II (type 1 A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 73: 439-447.
41. WEISMAN HF, BUSH DE, MANNIS JA, WEISFELDT ML, HEALY B, 1988. Cellular mechanisms of myocardial infarct expansion. Circulation 78: 186-201.
42. WOLLERT KC, STUDER R, VON BULOW B, DREXLER H, 1994. Survival after myocardial infarction in the rat: role of tissue angiotensin converting enzyme inhibition. Circulation 90: 2457-2467.
43. WONG PC, HART SD, ZASPEL AM, CHIU AT, ARDECKY RJ, SMITH RD, TIMMERMANS PBMWM, 1990. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: losartan (All-1) and PD123177 (All-2). J Pharmacol Exp Ther 255: 584-592.